John P. Leonard, MD, Weill Cornell Medicine
Advertisement
Articles by John P. Leonard, MD, Weill Cornell Medicine
Advertisement
Latest Updated Articles
Looking at the Big Picture in DLBCLPublished: August 23rd 2021 | Updated:
Treating Patients Post CAR T TherapyPublished: August 23rd 2021 | Updated:
Recommendations for Second-Line Therapy in DLBCLPublished: July 26th 2021 | Updated:
Dr. Leonard on the FDA Approval of Tazemetostat in Follicular LymphomaPublished: June 18th 2020 | Updated:
Exploring Emerging Data in DLBCLPublished: August 23rd 2021 | Updated:
Dr. Leonard on the Future of PI3K Inhibitors in Follicular LymphomaPublished: July 7th 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
3
Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma
4
Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma
5